Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy
Alimentary Pharmacology and Therapeutics, 07/01/09
Antolin M et al. - Faecal excretion of human DNA and calprotectin increased during pelvic radiotherapy treatment, and may be a good objective biomarker of intestinal damage in nonrectal cancer patients.
Related Articles
Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins
European Journal of Nutrition, 11/09/09
Relevance Score: 64%
Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity
Drug Development and Industrial Pharmacy, 10/23/09
Relevance Score: 63%
Review of 120 anal cancer patients
Colorectal Disease, 10/15/09
Relevance Score: 63%
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS Trial
Journal of Clinical Oncology, 10/30/09
Relevance Score: 47%
Effect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-I and IGFBP-3
World Journal of Gastroenterology, 11/18/09
Relevance Score: 46%
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/17/09
Distribution of advanced neoplasia according to polyp size at screening colonoscopy
Alimentary Pharmacology and Therapeutics, 12/17/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


